Sanara MedTech Inc. Announces The Acquisition Of Certain Assets Related To Its Collagen Products Business; The Initial Purchase Price For The Assets That Were Acquired By The Company Is $15.25M
Portfolio Pulse from Happy Mohamed
Sanara MedTech Inc. (NASDAQ:SMTI) has announced the acquisition of certain assets related to its collagen products business from Applied Nutritionals, LLC, The Hymed Group Corporation, and Dr. George Petito. The initial purchase price for the assets is $15.25 million. The acquisition is a major milestone for Sanara's strategy to own the intellectual property for its hydrolyzed collagen products and control its manufacturing to reduce costs and expand R&D efforts.
August 04, 2023 | 11:18 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Sanara MedTech's acquisition of assets related to its collagen products business could potentially reduce costs and expand R&D efforts, which may positively impact the company's financial performance.
The acquisition of these assets allows Sanara MedTech to eliminate royalties paid to the sellers, control the manufacturing process, and develop new collagen products. This could lead to cost reductions and increased innovation, potentially improving the company's financial performance and stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100